MP37-01 A COST-UTILITY ANALYSIS OF ENFORTUMAB VEDOTIN AND PEMBROLIZUMAB VERSUS NIVOLUMAB PLUS GEMCITABINE-CISPLATIN IN ADVANCED UROTHELIAL CARCINOMA Journal Articles uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Identity
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Cheung, Douglas C
  • Bernardino, Rui
  • May, Jacqueline A
  • Papasideris, Mia
  • Bremner, Karen E
  • Fleshner, Neil E
  • Lalani, Aly-Khan
  • Ong, Michael
  • Wong, William L
  • Wallis, Christopher
  • Kulkarni, Girish S

publication date

  • May 2025